This combination might be beneficial in breast cancer metastasized in bones because TRAF6 is overexpressed on osteotropic breast cancer cells and even greater levels of this protein are detected in patients with bone metastasis [202]. This evidence concerns the gene TRAF6 and breast carcinoma.